Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients

Clinical trial NCT05841342 · UNKNOWN

Trial details

NCT number: NCT05841342
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Secondary Hemophagocytic Lymphohistiocytosis Chronic Active Epstein-Barr Virus Infection

Start date: 2022-10-01
Primary completion: 2024-04-30
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.